PR-619: Practical DUB Inhibition Workflow
2026-08-09
This dossier-based guide explains how PR-619 can be used to perturb cysteine-dependent deubiquitylating enzymes in cell-based ubiquitination and autophagy experiments. It is useful for exploratory pathway studies, but its broad and reversible activity should not be interpreted as proof of inhibition of one DUB, proteasomal catalysis, or a disease-specific mechanism.
HyperScribe T7 High Yield Cy5 RNA Labeling Kit Guide
2026-08-08
Build fluorescent RNA probes for in situ hybridization and Northern blot hybridization with a tunable Cy5-UTP substitution strategy. This workflow connects transcript-level validation of engineered macrophage studies with practical probe synthesis, quality control, and troubleshooting.
A-1331852: BCL-XL Inhibitor Workflow Guide
2026-08-07
A-1331852 provides a selective, nanomolar tool for testing BCL-XL dependence, apoptotic priming, and BCL-XL–BIM complex disruption. This practical guide connects compound handling with viability, mitochondrial apoptosis, genetic validation, and combination-study workflows for cancer research.
C. difficile Responses to Human Mucus: A Novel IEC Model Stu
2026-08-07
This study introduces an innovative primary human intestinal epithelial cell (IEC) co-culture system to model physiologic mucus, enabling precise investigation of Clostridioides difficile's interactions with the human gut barrier. The work reveals how human-derived mucus influences C. difficile growth, metabolism, and biofilm formation, providing new insight into pathogenesis and potential intervention strategies.
ACSL1-FSP1 Axis Drives Ferroptosis Resistance in Ovarian Can
2026-08-06
This study uncovers how ACSL1 enhances ferroptosis resistance and platinum chemotherapy survival in ovarian cancer by increasing FSP1 N-myristoylation and stability. The findings highlight a critical metabolic adaptation in tumor spheroids, opening avenues for targeting ferroptosis pathways in resistant cancers.
BOP Reagent in Peptide Synthesis: Applied Workflows & OSCC I
2026-08-06
BOP reagent (benzotriazol-1-yloxy-tris(dimethylamino)phosphanium hexafluorophosphate) is transforming peptide synthesis with robust carboxyl group activation, enabling advanced prodrug strategies in oncology. This article delivers stepwise protocol guidance, real-world troubleshooting, and analysis of its pivotal role in carrier-free, self-assembling triterpene-based prodrug design for targeted OSCC therapy.
Oscillatory mTORC1 Activity Regulates Cell Cycle and Autopha
2026-08-05
Joshi et al. reveal that mTORC1 activity is not static but cyclically regulated across the cell cycle, peaking in S/G2 and reaching its nadir during mitosis and G1. This dynamic regulation orchestrates both mitotic entry and autophagy sensitivity, providing new mechanistic insight into how proliferating cells coordinate metabolic and division cues.
Eltanexor (KPT-8602): Translational Insights for XPO1-Target
2026-08-05
Explore how Eltanexor (KPT-8602), a next-generation XPO1 inhibitor, is reshaping cancer therapeutics through precise nuclear export modulation. This deep dive reveals unique mechanistic insights, highlights pivotal new findings, and offers advanced guidance for translational and assay-focused researchers.
Technical Guidance: Mc-Val-Cit-PABC-PNP ADC Peptide Linker U
2026-08-04
Mc-Val-Cit-PABC-PNP addresses the need for a cathepsin B-cleavable ADC peptide linker optimized for organic solvent-based antibody-drug conjugate (ADC) synthesis, enabling controlled payload release in targeted cancer research. It is not suitable for aqueous, diagnostic, or clinical applications. Researchers should follow solvent compatibility and storage protocols to ensure reproducibility.
CD36-Driven Lipid Metabolism Promotes Immune Escape in AML
2026-08-04
Guo et al. (2024) uncover a CD36-dependent, non-canonical lipid metabolism program in AML that enables immune escape and resistance to hypomethylating therapy by suppressing T cell function. Their mechanistic work reveals how targeting the CD36 axis may improve therapeutic outcomes, providing a new translational angle for immunometabolic intervention in leukemia.
AZD6482: Precision PI3Kβ Inhibition for Translational Discov
2026-08-03
This article examines the strategic and mechanistic rationale for deploying AZD6482—a highly selective PI3Kβ inhibitor—in advanced translational research. Integrating pathway insight, experimental guidance, and sectoral context, it synthesizes the latest findings in PI3K/Akt/mTOR biology while mapping the compound's unique translational potential. Drawing from recent evidence on RNA foci modulation in myotonic dystrophy and comparative pathway-targeted screening, the discussion offers actionable guidance for researchers seeking robust, context-driven experimental tools.
Propidium Iodide: DNA Intercalating Dye for Cell Viability A
2026-08-03
Propidium iodide stands out as a selective, red-fluorescent DNA intercalating dye, enabling robust cell viability assays, apoptosis detection, and cell cycle analysis. This guide delivers experimental workflows, actionable troubleshooting, and workflow enhancements to achieve reproducible, publication-grade results—empowering researchers to tackle challenges from host-pathogen interactions to advanced immunology.
HyperScript RT SuperMix for qPCR: Enabling Precision in Comp
2026-08-02
Discover how HyperScript RT SuperMix for qPCR advances gene expression analysis by overcoming RNA structural complexity and low template concentration. This deep-dive highlights unique assay decisions, practical insights from recent metastasis research, and differentiates APExBIO's technology from conventional reverse transcription kits.
O-propargyl-puromycin (OPP) for Precision Protein Synthesis
2026-08-01
O-propargyl-puromycin (OPP) enables rapid, high-resolution detection of nascent protein synthesis, allowing researchers to dissect mitochondrial regulation of antibody production in B cells. Its click chemistry compatibility and workflow flexibility make it indispensable for cutting-edge proteomics and immunology research.
Neurogenetic Gradients of Nurr1+ Neurons in the Rat Claustru
2026-07-31
Fang et al. advance our understanding of the rat claustrum by delineating the developmental timing and spatial neurogenetic gradients of Nurr1-positive neurons. Their integration of EdU birthdating with in situ hybridization clarifies the sequential generation of claustral and lateral cortical populations, providing a robust developmental framework for further research.
458 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page